NATIXIS - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 186 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
NATIXIS ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,301,124
-9.4%
296,155
+12.9%
0.02%
-14.3%
Q2 2023$2,538,638
-81.1%
262,256
-78.6%
0.02%
-82.6%
Q1 2023$13,431,338
+218.9%
1,225,487
+25.7%
0.12%
+404.2%
Q4 2022$4,211,754
+331.1%
974,943
+662.0%
0.02%
+380.0%
Q3 2022$977,000
-90.1%
127,945
-87.2%
0.01%
-86.1%
Q2 2022$9,910,000
-20.0%
1,000,0000.0%0.04%
-16.3%
Q1 2022$12,380,000
+8.3%
1,000,000
+100.0%
0.04%
+10.3%
Q4 2021$11,435,000500,0000.04%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 111,608$2,470,0003.15%
ACT CAPITAL MANAGEMENT, LLC 180,000$3,983,0002.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 167,889$3,715,0001.92%
DG Capital Management, LLC 402,200$8,901,0001.81%
NEA Management Company, LLC 5,172,683$114,471,0001.36%
KESTRA PRIVATE WEALTH SERVICES, LLC 801,100$17,728,0000.99%
Altium Capital Management LP 144,000$3,187,0000.84%
HighMark Wealth Management LLC 50,569$1,119,0000.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 123,500$2,724,0000.66%
SEVEN EIGHT CAPITAL, LP 288,840$6,392,0000.62%
View complete list of AURINIA PHARMACEUTICALS INC shareholders